Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001214659-20-005493

Options or other derivatives

  • Director acquired 16,640 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MESSEMER DEBORAH M. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-05 Grant or award : show line 1 in the form Stock Option (Right to Buy) +16,640 16,640 D
Loading xslF345X03/marketforms-49013.xml…